Preimplantation Genetic Testing Market by Technology (Comparative Genomic Hybridization, Fluorescence in Situ Hybridization, Next-Generation Sequencing), Offering (Instruments Services, Reagents and Consumables, Software and Services), Procedure Type, App

Preimplantation Genetic Testing Market by Technology (Comparative Genomic Hybridization, Fluorescence in Situ Hybridization, Next-Generation Sequencing), Offering (Instruments Services, Reagents and Consumables, Software and Services), Procedure Type, Application, End User - Global Forecast 2023-2030

The Preimplantation Genetic Testing Market size was estimated at USD 557.55 million in 2022 and expected to reach USD 602.78 million in 2023, at a CAGR 11.58% to reach USD 1,340.40 million by 2030.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Preimplantation Genetic Testing Market.

• Based on Technology, market is studied across Comparative Genomic Hybridization, Fluorescence in Situ Hybridization, Next-Generation Sequencing, Polymerase Chain Reaction, and Single-Nucleotide Polymorphism. The Next-Generation Sequencing commanded largest market share of 32.51% in 2022, followed by Polymerase Chain Reaction.
• Based on Offering, market is studied across Instruments Services, Reagents and Consumables, and Software and Services. The Reagents and Consumables commanded largest market share of 56.25% in 2022, followed by Instruments Services.
• Based on Procedure Type, market is studied across Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening. The Preimplantation Genetic Diagnosis commanded largest market share of 72.85% in 2022, followed by Preimplantation Genetic Screening.
• Based on Application, market is studied across Aneuploidy, Gender Identification, HLA Typing, Single Gene Disorders, Structural Chromosomal Abnormalities, and X-Linked Disorders. The Structural Chromosomal Abnormalities is further studied across Deletions, Duplications, Inversions, and Translocations. The Structural Chromosomal Abnormalities commanded largest market share of 23.96% in 2022, followed by X-Linked Disorders.
• Based on End User, market is studied across Contract Research and Manufacturing Organizations, Hospitals, Diagnostic Labs, and Service Providers, and Research Laboratories & Academic Institutes. The Hospitals, Diagnostic Labs, and Service Providers commanded largest market share of 61.74% in 2022, followed by Research Laboratories & Academic Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 40.53% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Preimplantation Genetic Testing Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Preimplantation Genetic Testing Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Preimplantation Genetic Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., EUROPE IVF International s.r.o., Genea Limited, Illumina, Inc., Invicta Genetics, Invitae Corporation, MedGenome Inc., Natera, Inc., Ovation Fertility, Oxford Gene Technology IP Limited, PacGenomics, PerkinElmer, Inc., Progenesis Fertility Center, Quest Diagnostics Incorporated, Reproductive Genetic Innovations, LLC, Takara Bio USA, Inc., The Cooper Companies Inc., Thermo Fisher Scientific Inc., and Yikon Genomics (Shanghai) Co., Ltd..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Preimplantation Genetic Testing Market?
2. Which products, segments, applications, and areas hold the highest investment potential in the Preimplantation Genetic Testing Market?
3. What is the competitive strategic window for identifying opportunities in the Preimplantation Genetic Testing Market?
4. What are the latest technology trends and regulatory frameworks in the Preimplantation Genetic Testing Market?
5. What is the market share of the leading vendors in the Preimplantation Genetic Testing Market?
6. Which modes and strategic moves are suitable for entering the Preimplantation Genetic Testing Market?

Note: PDF & Excel + Online Access - 1 Year